Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.
Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal
Archived explainer. For the current picture see today's HUM page.
HUMANA INC (HUM) is up +5.05% in the latest session. Our newswire has captured 12 stories on HUM across 8 sources in the last 36 hours, with AI sentiment reading mixed (avg 57/100).
Humana (HUM) shares rose 5.05% to $399.19, driven primarily by analyst upgrades from TD Cowen that improved the earnings outlook for the health insurer. The stock had recently faced pressure from regulatory scrutiny and a proposed Medicare for All framework, but the new ratings helped reverse some of the prior decline.
TD Cowen upgraded Humana to Buy from Hold, citing an improved earnings outlook and a clearer path to profitability in Medicare Advantage. The firm set a price target of $485 and projected earnings above $40 per share by 2028. This upgrade follows a period of volatility for healthcare insurers, including Humana, UnitedHealth, and CVS Health, which saw shares plunge due to a new Medicare for All proposal and increased regulatory scrutiny of government health programs.
The upgrade comes amid ongoing legal and regulatory concerns. A pending investigation by SueWallSt examines whether Humana adequately disclosed its exposure to proposed Medicare Advantage audits, noting that the program accounts for roughly 80% of premiums. Additionally, a proposed rule allowing Medicare to claw back overbilling going back to 2018 has heightened scrutiny on private insurance plans.
The stock opened with a 2.6% gap from the prior close of $380.00, reaching a session high of $401.40 early in the trading day. Volume was 0.5 million shares, which is 0.4x the three-month daily average. Despite the recent gains, the stock remains down 13.3% over the last eight sessions from $438.06. Humana has a market cap of $46.3 billion, a P/E ratio of 37.0, and a net margin of 0.8%. The company’s 52-week range spans from $163.11 to $462.87.
Insider activity shows two sales totaling $2.6 million in the last 90 days, including transactions by Director Frederick Wayne A.I. and General Counsel Ventura Joseph C. Congressional disclosures indicate Donald J. Trump sold between $15,001 and $50,000 in July. Retail chatter on social media has focused on the TD Cowen upgrade and the impact of Medicare Advantage audits, with some users noting the stock’s exposure to regulatory changes.
Investors will monitor the progress of the SueWallSt investigation into Humana’s disclosure practices regarding Medicare Advantage exposure. The scheduled dividend payment of $0.885 per share is set for an effective date of October 30, 2026. Continued coverage of regulatory developments affecting Medicare Advantage profitability remains a key factor for the stock’s trajectory.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal
TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlook
TD Cowen upgrades UnitedHealth and Humana to Buy, with targets of $455 and $485; it sees Humana above $40 EPS in 2028.
TD Cowen upgrades Humana stock rating on earnings outlook
Humana is especially exposed to proposed Medicare Advantage audits, with the program accounting for roughly 80% of premiums. I rate HUM stock as Buy.
Selling your HUM shares after the November 18 Medicare Advantage selloff does not necessarily end your rights. SueWallSt notifies investors of a pending investigation into whether Humana adequately disclosed its exposure to Medicare Advantage audit and repayment risk. NEW YORK, Nov. 19,...
More on HUM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier HUM move explainers: 2026-11-20 · 2026-11-19 · 2026-11-18 · 2026-11-17 · 2026-10-12 · 2026-10-09 · 2026-09-25